The largest database of trusted experimental protocols

13 protocols using human serum albumin (hsa)

1

Immobilization of NK Cell Antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-human NKp46 antibody (clone 195314, R&D Systems, Minneapolis, MN, USA) and/or anti-human CD16 antibody (clone 3G8, Thermo Fisher Scientific, Waltham, MA, USA) (both 5 μg/mL) were prepared in phosphate-buffered saline (PBS; Kohjin Bio, Saitama, Japan) containing 0.1% human serum albumin (FUJIFILM Wako Pure Chemical, Tokyo, Japan). For antibody immobilization, 2 mL antibody solution was transferred to 6-well plates (Corning, Steuben, NY, USA) and incubated at 4 °C for >12 h. The antibody solution in the flask was removed, and the flask was washed with PBS and used for the human NK cell culture.
+ Open protocol
+ Expand
2

Biotin-labeled Protein Modification Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Biotin-labeled proteins were prepared by incubating 5 mg/ml BSA (Iwai Chemicals), human serum albumin (FUJIFILM Wako Pure Chemical, Inc), transferrin (FUJIFILM Wako Pure Chemical, Inc), and IgG (FUJIFILM Wako Pure Chemical, Inc) with a 10-fold molar Bt-PE-maleimide (Dojindo Laboratories) in PBS (10 mM sodium phosphate buffer (pH 7.4)) at 25 °C for 16 h. After incubation, the aliquots were dialyzed against PBS. The polyphenol-modified proteins were prepared by incubating 1 mg/ml proteins or biotinylated proteins with 2.5 mM polyphenols in PBS containing 10% dimethyl sulfoxide for 72 h at 37 °C under atmospheric oxygen. After incubation, the reactants were collected and dialyzed with PBS. The protein concentrations were measured by a bicinchoninic acid assay (Nacalai Tesque, Inc). Bt-AET was synthesized according to previous studies (28 ). The polyphenol-modified amino acid analogs were prepared upon incubation of 1 mM Bt-APA (Thermo Fisher Scientific, Inc) or Bt-AET with 2.5 mM polyphenols in PBS containing 10% dimethyl sulfoxide for 24 h at 37 °C under atmospheric oxygen. The oxidized Bt-APA was prepared according to a previous report (2 (link)).
+ Open protocol
+ Expand
3

Extracellular DNA Quantification Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Extracellular DNA was stained with 5 μm SYTOX Green (Life Technologies, Carlsbad, CA, USA), a fluorescent membrane‐impermeable DNA dye. Fluorescence was quantified using a microplate reader equipped with filters to detect excitation/emission maxima of 504/523 nm (EnSpire; PerkinElmer, Waltham, MA, USA). When indicated, neutrophils were stimulated with 20 or 200 nm PMA, or cultured in the presence of 100 U·mL−1 DNase I (TaKaRa, Osaka, Japan), 40 mg·mL−1 bovine serum albumin (BSA; Wako Pure Chemical Industries, Osaka, Japan), 40 mg·mL−1 human serum albumin (Wako), heat‐treated (complement‐inactivated) serum, protein G/A sepharose‐treated (immunoglobulin‐depleted) serum, 10 mm EDTA, or 5 or 20 mm N‐acetyl‐l‐cysteine (NAC; Wako).
+ Open protocol
+ Expand
4

Dot Blot Assay for Chemical-Specific IgGs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Levels of chemical-specific IgGs were determined using the dot blot assay which the co-author (TK) has developed and patented [15 –17 (link)]. In this study, the diagnostic antigens were obtained by mixing human serum albumin (Wako Pure Chemical, Japan.) with the resin precursors TDI (Wako) and TMA (Wako) in a 1:100 ratio at pH 10.8. Details of this procedure have been reported elsewhere [15 –17 (link)].
+ Open protocol
+ Expand
5

Immobilization of NKp46 and CD16 Antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-human NKp46 antibodies (clone 195,314, R&D Systems, Minneapolis, MN, USA) and anti-human CD16 antibodies (clone 3G8, Thermo Fisher Scientific, Waltham, MA, USA) (both 5 μg/mL) were prepared in phosphate-buffered saline (PBS; Kohjin Bio, Saitama, Japan) containing 0.1% human serum albumin (FUJIFILM Wako Pure Chemical, Tokyo, Japan). A 1.5 or 0.7 mL antibody solution was transferred to 24- or 12 well-well plates (Corning, Steuben, NY, USA) and incubated at 4 °C for >12 h for antibody immobilization. The antibody solution was then removed from the flask, the flask was washed with PBS, and subsequently used for human NKC culturing.
+ Open protocol
+ Expand
6

Investigating HDL Levels with ELISA Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fe(NH4)2(SO4)2, FeCl3, N,N′-diethyl-p-phenylenediamine, dextran sulfate sodium salt (molecular weight range, 36,000–50,000), MgCl2, and human serum albumin were purchased from Wako (Tokyo, Japan). Tert-butyl hydroperoxide (70% in water) was purchased from TCI (Tokyo, Japan). NaCl was from Sigma-Aldrich (Tokyo, Japan). HDL Human ELISA (enzyme-linked immunosorbent assay) Kit (ab125961) came from Abcam (Cambridge, UK). A Bolt LDS sample Buffer, Bolt Reducing Agent, and Bolt MOPS SDS Running Buffer were purchased from the Life Technologies Corporation (Carlsbad, CA, USA). The Precision Plus Protein Dual Color Standards were from Bio-Rad Laboratories, Inc. (Hercules, CA, USA). The OH pak SB-804HQ column was obtained from Showa Denko KK (Tokyo, Japan).
+ Open protocol
+ Expand
7

Evaluating PAF-Mediated Survival in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
A schematic schedule of the experimental procedure is shown in Figure 2A. To determine the effect of PAF on the survival of ICR mice, we divided the animals (6 weeks of age) into the following three groups: PAF group, CpG-A1585 + PAF group, and CpG-A1585 + MAFP + PAF group (N = 8 mice per group). ICR mice were i.p. injected with 50, 100, or 300 µg CpG-A1585 1, 3, and 5 days before PAF challenge. MAFP (1 mg/kg) was i.p. injected 20 min before CpG-A1585 injection. A stock solution of PAF was made in methanol, and the required aliquot was dried under a stream of nitrogen. PAF was then reconstituted in 0.5 ml PBS containing 0.1% human serum albumin (Wako Pure Chemical Industries, Ltd., Osaka, Japan) before use and administered i.p. into Swiss albino mice. After each treatment, animals were monitored for up to 60 min for survival.
+ Open protocol
+ Expand
8

Immobilization of Anti-NKp46 and Anti-CD16 Antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-human NKp46 antibodies (clone 195, 314, R&D Systems, Minneapolis, MN, USA) and anti-human CD16 antibodies (clone 3G8, Thermo Fisher Scientific, Waltham, MA, USA) (both, 5 mg/mL) were prepared in phosphate-buffered saline (PBS; Kohjin Bio, Saitama, Japan) containing 0.1% human serum albumin (FUJIFILM Wako Pure Chemical, Tokyo, Japan). The antibody solution (1.5 or 0.7 mL) was transferred to 24- or 12-well plates (Corning, Steuben, NY, USA) and incubated at 4 °C for >12 h for antibody immobilization. The antibody solution was then removed from the flask, the flask was washed with PBS, and subsequently used for human NKC culturing.
+ Open protocol
+ Expand
9

Standardized Urinary Bilirubin Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Reference bilirubin (ZZ-BR) solutions were prepared to generate a standard curve for the measurement of urinary UnaG-binding bilirubin (UUB). A total of 2 mg of bilirubin (98%) (FUJIFILM Wako Pure Chemical Co., Osaka, Japan) was dissolved in 2 mL of 0.1 mol/L NaOH, which was immediately neutralized with 1 mL of 0.1 mol/L phosphoric acid and then mixed with 7 mL of human serum albumin (HSA; albumin 5% I.V. 5 g/100 mL, Japan Blood Products Organization, Tokyo, Japan). The concentration of bilirubin in the preparation was measured using a BL-300 2-wavelength spectrophotometer (TOITU Co., Ltd., Tokyo, Japan) (455 nm, 575 nm). The bilirubin solution was diluted with phosphate-buffered saline (0.1 mol/L, pH 7.2) to desired concentrations. The above reagents, except HSA, were purchased from FUJIFILM Wako Pure Chemical Co. (Osaka, Japan).
+ Open protocol
+ Expand
10

3D Aggregation of hiPSCs for Tissue Engineering

Check if the same lab product or an alternative is used in the 5 most similar protocols
For 3-dimensional cell aggregates experiment, hiPSCs were dissociated into cell suspensions and seeded into 96 well U-bottom ultra-low attachment plates (PrimeSurface®, Sumitomo Bakelite, MS-9096U) in StemFit Basic03 (equivalent to AK03N without bFGF, Ajinomoto) in the presence of ROCK inhibitor (Y-27632, Wako, 034-24024). After aggregates with clear edges were formed, the culture medium was replaced with DMEM/F12 supplemented with 0.1% human serum albumin (HSA, Wako, 014-21543) and 10 ng bFGF (R&D, 236-EG). Aggregate cross-sectional area sizes were measured using Fiji ImageJ software (Schindelin et al., 2012 (link)). 1231A3 hiPSCs were used in all experiments unless otherwise stated.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!